Professor Matthew Kiernan AM awarded the 2024 GSK Award for Research Excellence
November 19, 2024Professor Matthew Kiernan AM, CEO and Institute Director at NeuRA and Scientia Professor of Neuroscience at UNSW, has won the prestigious 2024 GSK Award for Research Excellence for his work in neurodegenerative diseases.
New research sheds light on alcohol’s impact on brain activity in social drinkers
September 2, 2024Researchers at Neuroscience Research Australia (NeuRA) and UNSW Science have conducted a study examining the impact of alcohol on the electrical conductivity of the brain, highlighting its sedative effects.
NeuRA launches world’s largest clinical trial for phantom limb pain
September 2, 2024NeuRA is now recruiting for TITAN, the world’s largest clinical trial to date into potential treatments phantom limb pain.
NeuRA researchers uncover critical, often overlooked factor in mental health research
July 1, 2024Measuring wellbeing alongside measures of psychological distress will paint a more accurate and thorough picture of mental health, found scientists at Neuroscience Research Australia (NeuRA) and UNSW Sydney.
NeuRA and the Talent Development Project launch Music and Memories
April 9, 2024Emerging singer songwriters collaborate with people diagnosed with dementia to create original songs inspired by real life.
Mixed neurodegenerative pathologies, including CTE, found in multiple former elite-level Australian rugby code players
March 20, 2024The new case series, published today in the Journal of Neuropathology and Applied Neurobiology in collaboration with the University of Sydney, Alfred Health and Harvard Medical School, includes clinicopathological analysis of the brains of six former elite-level Australian rugby league and union players, donated to the Former Elite-Level Athlete Brain Health Research Program.
NeuRA research reveals complex interplay of nature and nurture in emotion and cognition
February 15, 2024The way our brain processes different emotional and cognitive tasks may be underpinned by common factors, find scientists from Neuroscience Research Australia (NeuRA) and UNSW Sydney.
Anti-inflammatory drug found to help adults with severe schizophrenia
January 23, 2024Research conducted at Neuroscience Research Australia has found that an injection of an anti-flammatory biological known as Canakinumab in patients with schizophrenia and elevated inflammation brought about a decrease in psychotic symptom severity and inflammation. The research was published in Brain, Behavior, and Immunity.
Gamified at-home exercises shown to effectively prevent falls in older people
January 17, 2024The way our brain processes different emotional and cognitive tasks may be underpinned by common factors, find scientists from Neuroscience Research Australia (NeuRA) and UNSW Sydney.
Researchers identify new potential neural signature of resilience in adults who have experienced early life stress
April 26, 2023Early life stress (ELS) is a well-known risk factor for mental health problems in adulthood.
Australian researchers take intergenerational practice into community settings to combat frailty
April 26, 2023Vivamus vitae libero et nulla laoreet placerat sit amet nec ante. In at lectus a arcu condimentum.
An effective new treatment for chronic back pain targets the nervous system
April 26, 2023A treatment that trains both the brain and the body has shown important effects on pain and disability, a new study has found.
A time of transformational change at Neuroscience Research Australia
April 26, 2023NeuRA’s new organisational strategy will see a much sharper focus on neurodegeneration, mental health and ageing well; an emphasis on clinical outcomes; and a search for partnerships which can enable greater scale and impact.
NSW Health funding to support new discoveries in neuroinflammation and the neurobiology of schizophrenia
April 26, 2023Schizophrenia affects one in 100 Australians and roughly 20 million people worldwide. For 70 – 80 per cent of people with schizophrenia, it is a chronic, lifelong condition.
NeuRA researchers awarded $4.5m in MRFF grants to improve lives of those with chronic pain
April 26, 2023In congratulating NeuRA’s Centre for Pain IMPACT researchers, Interim Chief Executive Officer, Carole Renouf, said this successful grant funding was a testament to their vision and ambition to increase equity of access to health care.
Mindgardens Neuroscience Network acknowledges the Traditional Owners of Country throughout Australia and recognises their continuing connection to land, waters and community. We pay our respect to them and their cultures, and to Elders past, present and emerging.
We acknowledge the voices of people with lived experience, their carers, families and kinship groups. We recognise the expertise acquired through living with a mental health, drug and alcohol or neurological disorder and acknowledge those who care for people on their recovery journey. We place lived experience at the heart of all that we do.
Brings together the strengths of four founding organisations
